|
Market Closed -
Other stock markets
|
After hours 20:08:46 | |||
| 687.20 EUR | -1.58% |
|
678.90 | -1.21% |
| 05-12 | Argenx SE Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM | |
| 05-12 | ARGENX : Bernstein reiterates its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50.91B | |||||
| 49.21B | |||||
| 23.69B | - | ||||
| 25.14B | - | ||||
| 17.81B | |||||
| 16.5B |
- Stock Market
- Equities
- ARGX Stock
- Charts argenx SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition